Published in Medical Letter on the CDC and FDA, December 19th, 2004
According to published research from the United States, "During HIV-1 infection or vaccination, HIV-1 envelope spikes elicit antibody responses. Neutralizing antibodies block viral entry by recognizing epitopes on spikes critical for their interaction with receptor, coreceptors or fusion. In contrast, non-neutralizing antibodies fail to do so because they recognize epitopes either buried or exposed but not critical for viral entry."
"Previously, we produced a high-affinity human mAb against the cluster II determinant of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.